A new trial co-led by the Ottawa Heart Institute and the Research Institute of the McGill University Health Centre shows that ...
A new trial co-led by the Ottawa Heart Institute and the Research Institute of the McGill University Health Centre shows that ...
OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...
“People with type 2 diabetes and a higher risk of cardiovascular disease who reported taking low-dose aspirin were much less ...
Some hospitals are taking a dramatic step to save mothers and babies after studies have shown too many doctors fail to follow ...
Adults 60 and older who are at risk of heart disease should not start taking a daily low-dose aspirin to prevent heart attack or stroke, according to the United States Preventive Services Task Force ...
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...